Business
Neuronetics Names Todd Cushman as Vice President, Business Development
With this new appointment, the market leader in transcranial magnetic stimulation will continue expanding treatment access for patients with Major Depressive
About this update from Neuronetics, Inc.
[{"type":"text","content":"With this new appointment, the market leader in transcranial magnetic stimulation will continue expanding treatment access for patients with Major Depressive Disorder\nMALVERN, Pa., June 01, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced today that Todd Cushman will join the company as Vice President, Business Development, effective immediately. Mr. Cushman will be responsible for international strategy and Company commercial operations, including contract manufacturing, field service and technical support. Anthony Pui, Vice President, International Commercial Development, will report to Mr. Cushman in his new role. “Todd’s appointment is a key step in our company’s growth, and I’m proud to have him on board,” said Keith J. Sullivan, President and CEO of Neuronetics. “His industry knowledge and extensive leadership experience across product development and global operations make him an asset to the team in expanding access to NeuroStar® Advanced Therapy for Mental Health and pursuing our mission to transform patient lives. There’s no telling what else we will accomplish with him at the helm of Neuronetics’ business development strategy.” Mr. Cushman brings more than 35 years of industry experience to the Company. Before joining Neuronetics, he was a founding member of Bioness, Inc., a medical technology company specializing in neurological rehabilitation and implantable products for pain management and held several leadership roles throughout his tenure – including president and CEO from 2013 to 2021. Prior, he held leadership positions at Medtronic, Inc., Acumed Medical Equipment, Inc., and American Hospital Supply Corp. Inc. (now Baxter, Inc.). He graduated from Brown University with a Bachelor of Arts and earned his Master of Business Administration from the Marshall School of Business at the University of Southern California. Mr. Cushman currently serves on the Boards of Directors for Voiceitt and the Alfred Mann Institute for Biomedical Development at the Technion, Israel Institute of Technology. “I’m excited to join Neuronetics at such a crucial moment in the fight against depression and mental health conditions,” sai...